Sai-Ching J Yeung, BS, R Ph, MS, Ph D, MD, FACP

Peer-Reviewed Articles

1. Aiham Qdaisat 1ORCID,Adriana H. Wechsler 1ORCID,Maria T. Cruz Carreras 1,Jazmin R. Menendez 1,Demis Lipe 1,Emily A. Highsmith 2,Mona Kamal 3ORCID,Aisha Al-Breiki 1,4,Cristhiam M. Rojas Hernandez 5ORCID,Carol C. Wu 6 andSai-Ching J. Yeung. Concomitant Deep Vein Thrombosis in Cancer Patients with Unsuspected Pulmonary Embolism. cancers, 2022.
2. Demis N. Lipe MD,Aiham Qdaisat MD,Eva Rajha MD,Aisha Al-Breiki MD,Maria T. Cruz Carrera, Patrick Chaftari MD,Sai-ching J. Yeung MD,Terry W. Rice MD. Characteristics and predictors of venous thrombosis recurrence in patients with cancer and catheter-related thrombosis, 2022.
3. Qdaisat A, Yeung S, Rojas Hernandez C, Samudrala P, Kamal M, Li Z, Wechsler A. Characteristics and Outcomes of Intracranial Hemorrhage in Cancer Patients Visiting the Emergency Department. Journal of Clinical Medicine, 2022.
4. Hudson M, Strassels S, Durham D, Siddique S, Adler D, Yeung S, Bernstein S, Baugh C, Coyne C, Grudzen C, Henning D, Klotz A, Madsen T, Pallin D, Rico J, Ryan R, Shapiro N, Swor R, Venkat A, Wilson J, Thomas C, Bischof J, Lyman G, Caterino J,. Examining pain among non- Hispanic Black and non- Hispanic White patients with cancer visiting emergency departments: CONCERN (Comprehensive Oncologic Emergencies Research Network). Academic Emergency Medicine, 2021.
5. Araji G, Maamari J, Ahmad F, Zareef R, Chaftari P, Yeung S. The Emerging Role of the Gut Microbiome in the Cancer Response to Immune Checkpoint Inhibitors: A Narrative Review. Innovations Journal, 2021.
6. He X, Ji J, Dai X, Qdaisat A, Esteva F, Hortobagyi G, Yeung S. Association of cardiovascular disease risk factors with late cardiotoxicity and survival in HER2-positive breast cancer survivors. Clinical Cancer Research, 2021.
7. XuexinHe, XiaolanDai, JialiJi, HongLiu, GanggangShi, Sai-Ching JimYeung. Nine-year median follow up of cardiotoxicity and efficacy of trastuzumab concurrently with anthracycline-based and anthracycline-free neoadjuvant chemotherapy in HER2-positive breast cancer patients. Elsevier, 2021.
8. Yeung S, Qdaisat A, Chaftari P, Lipe D, Merlin J, Rajha E, Wechsler A, Sandoval M, Viets J, Al-Breiki A, Shah M, Pandey R, Kamal M, Khattab O, Toale K, Wattana M, Elsayem A, Gaeta S, Brock P, Reyes-Gibby C, Alagappan K. Diagnosis and Management of Immune-Related Adverse Effects. The Practice of Emergency Medicine:1-23, 2020.
9. Sandoval M, Banala S, Cruz Carreras M, Lipe D, Yeung S, Hanna E, TOdd K, Alagappan K, Reyes Gibby C. Hypertension and Emergency Department Visits by Patients with Head and Neck Cancer. Journal of Cardiology & Cardiovascular Therapy 16(1). e-Pub 2020.
10. Qdaisat A, WU W, Lin J, Al Soud R, Yang Z,Hu Z, Gao S, Wu C, Liu X, Silvestre J, Hita A, Viets-Upchurch J, Adwan S, Qasem a, Cruz Carreras M, Jacobson K, Chaftari P, Abdel-Razeq H, Reyes-Gibby C, Yeung S. CLINICAL AND CANCER-RELATED PREDICTORS FOR THE VENOUS THROMBOEMBOLISM IN CANCER PATIENTS PRESENTING TO THE EMERGENCY DEPARTMENT. THE JOURNAL OF EMERGENCY MEDICINE. e-Pub 2020.
11. Qdaisat A, Soud RA, Wu CC, Rojas Hernandez CM, Li J, Meng QH, Abdel-Razeq H, Yeung SJ. Poor performance of D-dimer in excluding venous thromboembolism among patients with lymphoma and leukemia. Haematologica 104(6):e265-e268, 2019. e-Pub 2019. PMID: 30630988.
12. Thein KZ, Yeung SJ, Oo TH. Reply to M. Alexander et al. Asia Pac J Clin Oncol 15(3):185, 2019. e-Pub 2019. PMID: 30714343.
13. Lin Y, Dong H, Deng W, Lin W, Li K, Xiong X, Guo Y, Zhou F, Ma C, Chen Y, Ren H, Yang H, Dai N, Ma L, Meltzer SJ, Yeung SJ, Zhang H. Evaluation of Salivary Exosomal Chimeric GOLM1-NAA35 RNA as a Potential Biomarker in Esophageal Carcinoma. Clin Cancer Res 25(10):3035-3045, 2019. e-Pub 2019. PMID: 30745298.
14. Yam C, Esteva FJ, Patel MM, Raghavendra AS, Ueno NT, Moulder SL, Hess KR, Shroff GS, Hodge S, Koenig KH, Chavez Mac Gregor M, Griner RL, Yeung SJ, Hortobagyi GN, Valero V. Efficacy and safety of the combination of metformin, everolimus and exemestane in overweight and obese postmenopausal patients with metastatic, hormone receptor-positive, HER2-negative breast cancer: a phase II study. Invest New Drugs 37(2):345-351, 2019. e-Pub 2019. PMID: 30610588.
15. Liu W, Qdaisat A, Soliman PT, Ramondetta L, Lopez G, Narayanan S, Zhou S, Cohen L, Bruera E, Yeung SJ. Hypomagnesemia and Survival in Patients with Ovarian Cancer Who Received Chemotherapy with Carboplatin. Oncologist. e-Pub 2019. PMID: 30940743.
16. Caterino JM, Adler D, Durham DD, Yeung SJ, Hudson MF, Bastani A, Bernstein SL, Baugh CW, Coyne CJ, Grudzen CR, Henning DJ, Klotz A, Madsen TE, Pallin DJ, Reyes-Gibby CC, Rico JF, Ryan RJ, Shapiro NI, Swor R, Venkat A, Wilson J, Thomas CR, Bischof JJ, Lyman GH. Analysis of Diagnoses, Symptoms, Medications, and Admissions Among Patients With Cancer Presenting to Emergency Departments. JAMA Netw Open 2(3):e190979, 2019. e-Pub 2019. PMID: 30901049.
17. Maamari J, Yeung SJ, Chaftari PS. Diabetic ketoacidosis induced by a single dose of pembrolizumab. Am J Emerg Med 37(2):376.e1-376.e2, 2019. e-Pub 2018. PMID: 30361152.
18. Liu W, Qdaisat A, Lopez G, Narayanan S, Underwood S, Spano M, Reddy A, Guo Y, Zhou S, Yeung SC, Bruera E, Garcia MK, Cohen L. Acupuncture for Hot Flashes in Cancer Patients: Clinical Characteristics and Traditional Chinese Medicine Diagnosis as Predictors of Treatment Response. Integr Cancer Ther 18:1534735419848494, 2019. PMID: 31046489.
19. Ji J, Dai X, Yeung SJ, He X. The role of long non-coding RNA GAS5 in cancers. Cancer Manag Res 11:2729-2737, 2019. e-Pub 2019. PMID: 31114330.
20. El-Majzoub I, Qdaisat A, Chaftari PS, Yeung S-C, Sawaya RD, Jizzini M, Cruz Carreras MT, Abunafeesa H, Elsayem AF. Association of emergency department admission and early inpatient palliative care consultation with hospital mortality in a comprehensive cancer center. Supportive Care in Cancer, 2018.
21. Tai LW, Yeung SC, Cheung CW. Enriched Environment and Effects on Neuropathic Pain: Experimental Findings and Mechanisms. Pain Pract 18(8):1068-1082, 2018. e-Pub 2018. PMID: 29722923.
22. Han Q, Yeung SC, Ip MSM, Mak JCW. Dysregulation of cardiac lipid parameters in high-fat high-cholesterol diet-induced rat model. Lipids Health Dis 17(1):255, 2018. e-Pub 2018. PMID: 30428911.
23. Wang L, Li W, Li K, Guo Y, Liu D, Yao Z, Lin X, Li S, Jiang Z, Liu Q, Jiang Y, Zhang B, Chen L, Zhou F, Ren H, Lin D, Zhang D, Yeung SJ, Zhang H. The oncogenic roles of nuclear receptor coactivator 1 in human esophageal carcinoma. Cancer Med 00(10):1-12, 2018. e-Pub 2018. PMID: 30270520.
24. He X, Ji J, Dong R, Liu H, Dai X, Wang C, Esteva FJ, Yeung SJ. Prognosis in different subtypes of metaplastic breast cancer: a population-based analysis. Breast Cancer Res Treat. e-Pub 2018. PMID: 30341462.
25. El Majzoub I, Qdaisat A, Thein KZ, Win MA, Han MM, Jacobson K, Chaftari PS, Prejean M, Reyes-Gibby C, Yeung SJ. Adverse Effects of Immune Checkpoint Therapy in Cancer Patients visiting the Emergency Department of a Comprehensive Cancer Center. Ann Emerg Med. e-Pub 2018. PMID: 29880440.
26. Ahn S, Rice TW, Yeung SJ, Cooksley T. Comparison of the MASCC and CISNE scores for identifying low-risk neutropenic fever patients: analysis of data from three emergency departments of cancer centers in three continents. Support Care Cancer 26(5):1465-70, 2018. e-Pub 2017. PMID: 29168032.
27. Kelly RS, Lasky-Su J, Yeung SJ, Stone RM, Caterino JM, Hagan SC, Lyman GH. Integrative omics to detect bacteremia in patients with febrile neutropenia. PLoS One 13(5):e0197049, 2018. e-Pub 2018. PMID: 29768470.
28. Liu W, Qdaisat A, Yeung J, Lopez G, Weinberg JS, Zhou S, Cohen L, Bruera E, Yeung S-CJ. The association between common clinical characteristics and postoperative morbidity and overall survival in patients with glioblastoma. The Oncologist, 2018.
29. Reyes-Gibby CC, Wang J, Yeung SJ, Chaftari P, Yu RK, Hanna EY, Shete S. Genome-wide study identifies genes associated with neuropathy in patients with head and neck cancer. Sci Rep 8(18):8789, 2018. e-Pub 2018. PMID: 29884837.
30. Thein KZ, Yeung SJ, Oo TH. Primary thromboprophylaxis (PTP) in ambulatory patients with lung cancer receiving chemotherapy: A systematic review and meta-analysis of randomized controlled trials (RCTs). Asia Pac J Clin Oncol 14(3):210-16, 2018. e-Pub 2017. PMID: 28949077.
31. Banala SR, Yeung SJ, Rice TW, Reyes-Gibby CC, Wu CC, Todd KH, Peacock WF, Alagappan K. Discharge or admit? Emergency department management of incidental pulmonary embolism in patients with cancer: a retrospective study. Int J Emerg Med 10(1):19, 2017. e-Pub 2017. PMID: 28589462.
32. Ahn S, Rice TW, Yeung SJ, Cooksley T. Comparison of the MASCC and CISNE scores for identifying low-risk neutropenic fever patients: analysis of data from three emergency departments of cancer centers in three continents. Support Care Cancer. e-Pub 2017. PMID: 29168032.
33. Thein KZ, Yeung SJ, Oo TH. Primary thromboprophylaxis (PTP) in ambulatory patients with lung cancer receiving chemotherapy: A systematic review and meta-analysis of randomized controlled trials (RCTs). Asia Pac J Clin Oncol. e-Pub 2017. PMID: 28949077.
34. Elsayem AF, Bruera E, Valentine A, Warneke CL, Wood GL, Yeung SJ, Page VD, Silvestre J, Brock PA, Todd KH. Advance Directives, Hospitalization, and Survival Among Advanced Cancer Patients with Delirium Presenting to the Emergency Department: A Prospective Study. Oncologist. e-Pub 2017. PMID: 28765503.
35. Win MA, Thein KZ, Qdaisat A, Yeung SJ. Acute symptomatic hypocalcemia from immune checkpoint therapy-induced hypoparathyroidism. Am J Emerg Med 35(7):1039.e5-1039.e7, 2017. e-Pub 2017. PMID: 28363614.
36. Acharya GK, Hita AG, Yeung SJ, Yeung SJ. Diabetic Ketoacidosis and Acute Pancreatitis: Serious Adverse Effects of Everolimus. Ann Emerg Med 69(5):666-667, 2017. PMID: 28442095.
37. Win MA, Thein KZ, Yeung SJ. Cancer immunotherapy-induced posterior reversible encephalopathy syndrome in an ED. Am J Emerg Med 35(4):663.e1-663.e2, 2017. e-Pub 2016. PMID: 27836313.
38. Fuentes-Mattei E, Giza DE, Shimizu M, Ivan C, Manning JT, Tudor S, Ciccone M, Kargin OA, Zhang X, Mur P, do Amaral NS, Chen M, Tarrand JJ, Lupu F, Ferrajoli A, Keating MJ, Vasilescu C, Yeung SJ, Calin GA. Plasma Viral miRNAs Indicate a High Prevalence of Occult Viral Infections. EBioMedicine. e-Pub 2017. PMID: 28465156.
39. Dong H, Xu J, Li W, Gan J, Lin W, Ke J, Jiang J, Du L, Chen Y, Zhong X, Zhang D, Yeung SJ, Li X, Zhang H. Reciprocal androgen receptor/interleukin-6 crosstalk drives oesophageal carcinoma progression and contributes to patient prognosis. J Pathol 241(4):448-462, 2017. e-Pub 2017. PMID: 27801498.
40. Reyes-Gibby CC, Melkonian SC, Hanna EY, Yeung SJ, Lu C, Chambers MS, Banala SR, Gunn GB, Shete SS. Cohort study of oncologic emergencies in patients with head and neck cancer. Head Neck. e-Pub 2017. PMID: 28346771.
41. Reyes-Gibby CC, Melkonian SC, Wang J, Yu RK, Shelburne SA, Lu C, Gunn GB, Chambers MS, Hanna EY, Yeung SJ, Shete S. Identifying novel genes and biological processes relevant to the development of cancer therapy-induced mucositis: An informative gene network analysis. PLoS One 12(7):e0180396, 2017. e-Pub 2017. PMID: 28678827.
42. Vasilescu C, Dragomir M, Tanase M, Giza D, Purnichescu-Purtan R, Chen M, Yeung SJ, Calin GA. Circulating miRNAs in sepsis-A network under attack: An in-silico prediction of the potential existence of miRNA sponges in sepsis. PLoS One 12(8):e0183334, 2017. e-Pub 2017. PMID: 28820886.
43. Yang F, Lei Q, Li L, He JC, Zeng J, Luo C, Yeung SJ, Yang R. Delivery of epirubicin via slow infusion as a strategy to mitigate chemotherapy-induced cardiotoxicity. PLoS One 12(11):e0188025, 2017. e-Pub 2017. PMID: 29131861.
44. Win MA, Thein KZ, Yeung SJ. Cancer immunotherapy-induced posterior reversible encephalopathy syndrome in an ED. Am J Emerg Med 35(4):663 e1-e2, 2017. e-Pub 2016. PMID: 27836313.
45. Giza DE, Fuentes-Mattei E, Bullock MD, Tudor S, Goblirsch MJ, Fabbri M, Lupu F, Yeung SJ, Vasilescu C, Calin GA. Cellular and viral microRNAs in sepsis: mechanisms of action and clinical applications. Cell Death Differ. e-Pub 2016. PMID: 27740627.
46. Kolb R, Phan L, Borcherding N, Liu Y, Yuan F, Janowski AM, Xie Q, Markan KR, Li W, Potthoff MJ, Fuentes-Mattei E, Ellies LG, Knudson CM, Lee MH, Yeung SJ, Cassel SL, Sutterwala FS, Zhang W. Obesity-associated NLRC4 inflammasome activation drives breast cancer progression. Nat Commun 7:13007, 2016. e-Pub 2016. PMID: 27708283.
47. Elsayem AF, Bruera E, Valentine AD, Warneke CL, Yeung SC, Page VD, Wood GL, Silvestre J, Holmes HM, Brock PA, Todd KH. Delirium frequency among advanced cancer patients presenting to an emergency department: A prospective, randomized, observational study. Cancer 122(18):2918-24, 2016. e-Pub 2016. PMID: 27455035.
48. Miller AH, Brock P, Jim Yeung SC. Pituitary Dysfunction: A Case Series of Immune Checkpoint Inhibitor-Related Hypophysitis in an Emergency Department. Ann Emerg Med 68(2):249-50, 2016. PMID: 27451306.
49. Tu SM, Bilen MA, Hess KR, Broaddus RR, Kopetz S, Wei C, Pagliaro LC, Karam JA, Ward JF, Wood CG, Rao P, Tu ZH, General R, Chen AH, Nieto YL, Yeung SC, Lin SH, Logothetis CJ, Pisters LL. Intratumoral heterogeneity: Role of differentiation in a potentially lethal phenotype of testicular cancer. Cancer 122(12):1836-43, 2016. e-Pub 2016. PMID: 27018785.
50. Dong H, Ma L, Gan J, Lin W, Chen C, Yao Z, Du L, Zheng L, Ke C, Huang X, Song H, Kumar R, Yeung SC, Zhang H. PTPRO represses ERBB2-driven breast oncogenesis by dephosphorylation and endosomal internalization of ERBB2. Oncogene. e-Pub 2016. PMID: 27345410.
51. Elsayem AF, Merriman KW, Gonzalez CE, Yeung SC, Chaftari PS, Reyes-Gibby C, Todd KH. Presenting Symptoms in the Emergency Department as Predictors of Intensive Care Unit Admissions and Hospital Mortality in a Comprehensive Cancer Center. J Oncol Pract 12(5):e554-63, 2016. e-Pub 2016. PMID: 27072570.
52. Miller AH, Yeung SC. Hypercortisolism Manifesting as Severe Weight Loss, Hypokalemia, and Hyperglycemia in the Emergency Department. J Emerg Med 50(4):e187-90, 2016. e-Pub 2016. PMID: 26896288.
53. Yang Z, Qdaisat A, Hu Z, Wagar EA, Reyes-Gibby C, Meng QH, Yeung SC. Cardiac Troponin Is a Predictor of Septic Shock Mortality in Cancer Patients in an Emergency Department: A Retrospective Cohort Study. PLoS One 11(4):e0153492, 2016. e-Pub 2016. PMID: 27077648.
54. Reyes-Gibby CC, Wang J, Silvas MR, Yu R, Yeung SC, Shete S. MAPK1/ERK2 as novel target genes for pain in head and neck cancer patients. BMC Genet 17:40, 2016. e-Pub 2016. PMID: 26872611.
55. Bankson JA, Walker CM, Ramirez MS, Stefan W, Fuentes D, Merritt ME, Lee J, Sandulache VC, Chen Y, Phan L, Chou PC, Rao A, Yeung SC, Lee MH, Schellingerhout D, Conrad CA, Malloy C, Sherry AD, Lai SY, Hazle JD. Kinetic Modeling and Constrained Reconstruction of Hyperpolarized [1-13C]-Pyruvate Offers Improved Metabolic Imaging of Tumors. Cancer Res 75(22):4708-17, 2015. e-Pub 2015. PMID: 26420214.
56. Phan LM, Fuentes-Mattei E, Wu W, Velazquez-Torres G, Sircar K, Wood CG, Hai T, Jimenez C, Cote GJ, Ozsari L, Hofmann MC, Zheng S, Verhaak R, Pagliaro L, Cortez MA, Lee MH, Yeung SC, Habra MA. Hepatocyte Growth Factor/cMET Pathway Activation Enhances Cancer Hallmarks in Adrenocortical Carcinoma. Cancer Res 75(19):4131-42, 2015. e-Pub 2015. PMID: 26282167.
57. Gao S, Fang L, Phan LM, Qdaisat A, Yeung SC, Lee MH. COP9 signalosome subunit 6 (CSN6) regulates E6AP/UBE3A in cervical cancer. Oncotarget 6(29):28026-41, 2015. PMID: 26318036.
58. Fang L, Lu W, Choi HH, Yeung SC, Tung JY, Hsiao CD, Fuentes-Mattei E, Menter D, Chen C, Wang L, Wang J, Lee MH. ERK2-Dependent Phosphorylation of CSN6 Is Critical in Colorectal Cancer Development. Cancer Cell 28(2):183-97, 2015. PMID: 26267535.
59. Dasari A, Phan A, Gupta S, Rashid A, Yeung SC, Hess K, Chen H, Tarco E, Chen H, Wei C, Anh-Do K, Halperin D, Meric-Bernstam F, Yao J. Phase I study of the anti-IGF1R antibody cixutumumab with everolimus and octreotide in advanced well-differentiated neuroendocrine tumors. Endocr Relat Cancer 22(3):431-41, 2015. e-Pub 2015. PMID: 25900182.
60. Zhou DS, Wang HB, Zhou ZG, Zhang YJ, Zhong Q, Xu L, Huang YH, Yeung SC, Chen MS, Zeng MS. TACC3 promotes stemness and is a potential therapeutic target in hepatocellular carcinoma. Oncotarget. e-Pub 2015. PMID: 26219398.
61. Choi HH, Su CH, Fang L, Zhang J, Yeung SC, Lee MH. CSN6 deregulation impairs genome integrity in a COP1-dependent pathway. Oncotarget 6(14):11779-93, 2015. PMID: 25957415.
62. Li Z, Zou X, Xie L, Chen H, Chen Y, Yeung SC, Zhang H. Personalizing risk stratification by addition of PAK1 expression to TNM staging: improving the accuracy of clinical decision for gastroesophageal junction adenocarcinoma. Int J Cancer 136(7):1636-45, 2015. e-Pub 2014. PMID: 25159681.
63. Wu W, Liu X, Chaftari P, Cruz Carreras MT, Gonzalez C, Viets-Upchurch J, Merriman K, Tu SM, Dalal S, Yeung SC. Association of body composition with outcome of docetaxel chemotherapy in metastatic prostate cancer: a retrospective review. PLoS One 10(3):e0122047, 2015. e-Pub 2015. PMID: 25822612.
64. Bilen MA, Lin SH, Tang DG, Parikh K, Lee MH, Yeung SC, Tu SM. Maintenance Therapy Containing Metformin and/or Zyflamend for Advanced Prostate Cancer: A Case Series. Case Rep Oncol Med 2015:471861, 2015. e-Pub 2015. PMID: 25861496.
65. Reyes-Gibby CC, Wang J, Yeung SC, Shete S. Informative gene network for chemotherapy-induced peripheral neuropathy. BioData Min 8:24, 2015. e-Pub 2015. PMID: 26269716.
66. Reyes-Gibby CC, Yuan C, Wang J, Yeung SC, Shete S. Gene network analysis shows immune-signaling and ERK1/2 as novel genetic markers for multiple addiction phenotypes: alcohol, smoking and opioid addiction. BMC Syst Biol 9:25, 2015. e-Pub 2015. PMID: 26044620.
67. Phan L, Chou PC, Velazquez-Torres G, Samudio I, Parreno K, Huang Y, Tseng C, Vu T, Gully C, Su CH, Wang E, Chen J, Choi HH, Fuentes-Mattei E, Shin JH, Shiang C, Grabiner B, Blonska M, Skerl S, Shao Y, Cody D, Delacerda J, Kingsley C, Webb D, Carlock C, Zhou Z, Hsieh YC, Lee J, Elliott A, Ramirez M, Bankson J, Hazle J, Wang Y, Li L, Weng S, Rizk N, Wen YY, Lin X, Wang H, Wang H, Zhang A, Xia X, Wu Y, Habra M, Yang W, Pusztai L, Yeung SC, Lee MH. The cell cycle regulator 14-3-3σ opposes and reverses cancer metabolic reprogramming. Nat Commun 6:7530, 2015. e-Pub 2015. PMID: 26179207.
68. Li D, Mao Y, Chang P, Liu C, Hassan MM, Yeung SJ, Abbruzzese JL. Impacts of new-onset and long-term diabetes on clinical outcome of pancreatic cancer. Am J Cancer Res 5(10):3260-9, 2015. e-Pub 2015. PMID: 26693076.
69. Pérez CM, Ortiz AP, Fuentes-Mattei E, Velázquez-Torres G, Santiago D, Giovannetti K, Bernabe R, Lee MH, Yeung SC. High Prevalence of Cardiometabolic Risk Factors in Hispanic Adolescents: Correlations with Adipocytokines and Markers of Inflammation. J Immigr Minor Health 16(5):865-73, 2014. e-Pub 2013. PMID: 23828626.
70. Bazerbashi H, Merriman KW, Toale KM, Chaftari P, Cruz Carreras MT, Henderson JD, Yeung SC, Rice TW. Low tissue oxygen saturation at emergency center triage is predictive of intensive care unit admission. J Crit Care 29(5):775-9, 2014. e-Pub 2014. PMID: 24973103.
71. Li X, Zhang Y, Yeung SC, Liang Y, Liang X, Ding Y, Ip MS, Tse HF, Mak JC, Lian Q. Mitochondrial transfer of induced pluripotent stem cell-derived mesenchymal stem cells to airway epithelial cells attenuates cigarette smoke-induced damage. Am J Respir Cell Mol Biol 51(3):455-65, 2014. PMID: 24738760.
72. O'Connor G, McGinty T, Yeung SJ, O'Shea D, Macken A, Brazil E, Mallon P. Cross-sectional study of the characteristics, healthcare usage, morbidity and mortality of injecting drug users attending an inner city emergency department. Emerg Med J 31(8):625-9, 2014. e-Pub 2013. PMID: 23625509.
73. Fuentes-Mattei E, Velazquez-Torres G, Phan L, Zhang F, Chou PC, Shin JH, Choi HH, Chen JS, Zhao R, Chen J, Gully C, Carlock C, Qi Y, Zhang Y, Wu Y, Esteva FJ, Luo Y, McKeehan WL, Ensor J, Hortobagyi GN, Pusztai L, Fraser Symmans W, Lee MH, Yeung SC. Effects of obesity on transcriptomic changes and cancer hallmarks in estrogen receptor-positive breast cancer. J Natl Cancer Inst 106(7), 2014. e-Pub 2014. PMID: 24957076.
74. Wu W, Merriman K, Nabaah A, Seval N, Seval D, Lin H, Wang M, Qazilbash MH, Baladandayuthapani V, Berry D, Orlowski RZ, Lee MH, Yeung SC. The association of diabetes and anti-diabetic medications with clinical outcomes in multiple myeloma. Br J Cancer 111(3):628-36, 2014. e-Pub 2014. PMID: 24921909.
75. Phan LM, Yeung SC, Lee MH. Cancer Metabolic Reprogramming: Importance, Main Features, and Potentials for Precise Targeted Anti-Cancer Therapies. Cancer Biol Med 11(1):1-19, 2014. PMID: 24738035.
76. Lai YR, Hong JM, Liu ZG, Deng ZS, Yeung SCJ, Cheng C. Bilateral Pulmonary Artery Aneurysms, Coronary Artery Aneurysm and Ventricular Pseudoaneurysm in Behcet’s Disease. Ann Vasc Surgery 28:741.e7-741.e10, 2014. e-Pub 2014.
77. Chen J, Shin JH, Zhao R, Phan L, Wang H, Xue Y, Post SM, Ho Choi H, Chen JS, Wang E, Zhou Z, Tseng C, Gully C, Velazquez-Torres G, Fuentes-Mattei E, Yeung G, Qiao Y, Chou PC, Su CH, Hsieh YC, Hsu SL, Ohshiro K, Shaikenov T, Wang H, Yeung SC, Lee MH. CSN6 drives carcinogenesis by positively regulating Myc stability. Nat Commun 5:5384, 2014. e-Pub 2014. PMID: 25395170.
78. Tudor S, Giza DE, Lin HY, Fabris L, Yoshiaki K, D'Abundo L, Toale KM, Shimizu M, Ferracin M, Challagundla KB, Cortez MA, Fuentes-Mattei E, Tulbure D, Gonzalez C, Henderson J, Row M, Rice TW, Ivan C, Negrini M, Fabbri M, Morris JS, Yeung SC, Vasilescu C, Calin GA. Cellular and Kaposi's sarcoma-associated herpes virus microRNAs in sepsis and surgical trauma. Cell Death Dis 5:e1559, 2014. e-Pub 2014. PMID: 25476907.
79. Feng Y, Ke C, Tang Q, Dong H, Zheng X, Lin W, Ke J, Huang J, Yeung SC, Zhang H. Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating Stat3 signaling. Cell Death Dis 5:e1088, 2014. e-Pub 2014. PMID: 24577086.
80. Ost DE, Yeung SC, Tanoue LT, Gould MK. Clinical and organizational factors in the initial evaluation of patients with lung cancer: Diagnosis and management of lung cancer, 3rd Edition: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143(5 Suppl):e121S-41S, 2013. PMID: 23649435.
81. Hanzelka KM, Yeung SC, Chisholm G, Merriman KW, Gaeta S, Malik I, Rice TW. Implementation of modified early-goal directed therapy for sepsis in the emergency center of a comprehensive cancer center. Support Care Cancer 21(3):727-34, 2013. e-Pub 2012. PMID: 22956191.
82. Zhao R, Yang HY, Shin J, Phan L, Fang L, Che TF, Su CH, Yeung SC, Lee MH. CDK inhibitor p57 (Kip2) is downregulated by Akt during HER2-mediated tumorigenicity. Cell Cycle 12(6):935-43, 2013. e-Pub 2013. PMID: 23421998.
83. Esteva FJ, Moulder SL, Gonzalez-Angulo AM, Ensor J, Murray JL, Green MC, Koenig KB, Lee MH, Hortobagyi GN, Yeung SC. Phase I trial of exemestane in combination with metformin and rosiglitazone in nondiabetic obese postmenopausal women with hormone receptor-positive metastatic breast cancer. Cancer Chemother Pharmacol 71(1):63-2, 2013. e-Pub 2012. PMID: 23053261.
84. Yeung SC, Elsayem A, Fuller GN, Lu G, You MJ. Fatal acute monocytic leukemia with t(6;11)(q27;q23) translocation and KRAS mutation. J Clin Pathol 66(1):73-5, 2013. e-Pub 2012. PMID: 22923764.
85. Yang C, Lu W, Lin T, You P, Ye M, Huang Y, Jiang X, Wang C, Wang F, Lee MH, Yeung SC, Johnson RL, Wei C, Tsai RY, Frazier ML, McKeehan WL, Luo Y. Activation of Liver FGF21 in hepatocarcinogenesis and during hepatic stress. BMC Gastroenterol 13:67, 2013. e-Pub 2013. PMID: 23590285.
86. Luo Y, Yang C, Ye M, Jin C, Abbruzzese JL, Lee MH, Yeung SC, McKeehan WL. Deficiency of metabolic regulator FGFR4 delays breast cancer progression through systemic and microenvironmental metabolic alterations. Cancer Metab 1(1):21, 2013. e-Pub 2013. PMID: 24279986.
87. Wen YY, Chou PC, Phan L, Su CH, Chen J, Hsieh YC, Xue YW, Qu CJ, Gully C, Parreno K, Teng C, Hsu SL, Yeung SC, Wang HM, Lee MH. DNA damage-mediated c-Myc degradation requires 14-3-3 sigma. Cancer Hallmarks 1:3-17, 2013.
88. Luo CQ, Yeung SC, Liu ZG, Meng J, Zhong FT, Cheng C. Pulmonary well-differentiated fetal adenocarcinoma with platelet-derived growth factor receptor (PDGFR)α expression. Cancer Biol Ther 13(14):1384-89, 2012. e-Pub 2012. PMID: 22986233.
89. Chen B, Zhao R, Su CH, Linan M, Tseng C, Phan L, Fang L, Yang HY, Yang H, Wang W, Xu X, Jiang N, Cai S, Jin F, Yeung SC, Lee MH. CDK inhibitor p57 (Kip2) is negatively regulated by COP9 signalosome subunit 6. Cell Cycle 11(24):4633-41, 2012. e-Pub 2012. PMID: 23187808.
90. Xue Y, Chen J, Choi HH, Phan L, Chou PC, Zhao R, Yang H, Santiago J, Liu M, Yeung GE, Yeung SC, Lee MH. HER2-Akt signaling in regulating COP9 signalsome subunit 6 and p53. Cell Cycle 11(22):4181-90, 2012. e-Pub 2012. PMID: 23095642.
91. Teng CL, Hsieh YC, Phan L, Shin J, Gully C, Velazquez-Torres G, Skerl S, Yeung SC, Hsu SL, Lee MH. FBXW7 is involved in Aurora B degradation. Cell Cycle 11(21):4059-68, 2012. e-Pub 2012. PMID: 23095493.
92. Vu K, Busaidy N, Cabanillas ME, Konopleva M, Faderl S, Thomas DA, O'Brien S, Broglio K, Ensor J, Escalante C, Andreeff M, Kantarjian H, Lavis V, Yeung SC. A randomized controlled trial of an intensive insulin regimen in patients with hyperglycemic acute lymphoblastic leukemia. Clin Lymphoma Myeloma Leuk 12(5):355-62, 2012. e-Pub 2012. PMID: 22658895.
93. Tu SM, Som A, Tu B, Logothetis CJ, Lee MH, Yeung SC. Effect of Paget's disease of bone (osteitis deformans) on the progression of prostate cancer bone metastasis. Br J Cancer 107(4):646-51, 2012. e-Pub 2012. PMID: 22805323.
94. He X, Esteva FJ, Ensor J, Hortobagyi GN, Lee MH, Yeung SC. Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer. Ann Oncol 23(7):1771-80, 2012. e-Pub 2011. PMID: 22112968.
95. Gully CP, Velazquez-Torres G, Shin JH, Fuentes-Mattei E, Wang E, Carlock C, Chen J, Rothenberg D, Adams HP, Choi HH, Guma S, Phan L, Chou PC, Su CH, Zhang F, Chen JS, Yang TY, Yeung SC, Lee MH. Aurora B kinase phosphorylates and instigates degradation of p53. Proc Natl Acad Sci U S A 109(24):E1513-22, 2012. e-Pub 2012. PMID: 22611192.
96. Pan J, Chen C, Jin Y, Fuentes-Mattei E, Velazquez-Tores G, Benito JM, Konopleva M, Andreeff M, Lee MH, Yeung SC. Differential impact of structurally different anti-diabetic drugs on proliferation and chemosensitivity of acute lymphoblastic leukemia cells. Cell Cycle 11(12):2314-26, 2012. e-Pub 2012. PMID: 22659796.
97. Sadeghi N, Abbruzzese JL, Yeung SC, Hassan M, Li D. Metformin use is associated with better survival of diabetic patients with pancreatic cancer. Clin Cancer Res 18(10):2905-12, 2012. e-Pub 2012. PMID: 22465831.
98. Wu Y, Chen C, Sun X, Shi X, Jin B, Ding K, Yeung SC, Pan J. Cyclin-dependent kinase 7/9 inhibitor SNS-032 abrogates FIP1-like-1 platelet-derived growth factor receptor α and bcr-abl oncogene addiction in malignant hematologic cells. Clin Cancer Res 18(7):1966-78, 2012. e-Pub 2012. PMID: 22447844.
99. Matthias N, Lockworth CR, Zhang F, Lee MH, Yeung SC, Tsai KY, Hamir AN. Multiple cystic sweat gland tumors in transgenic mice. Comp Med 62(1):27-30, 2012. PMID: 22330648.
100. Matthias N, Lockworth CR, Zhang F, Lee MH, Yeung SC, Tsai KY, Hamir AN. Multiple cystic sweat gland tumors in transgenic mice. Comp Med 62(1):27-30, 2012. e-Pub 2012. PMID: 22330648.
101. He XX, Tu SM, Lee MH, Yeung SC. Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients. Ann Oncol 22(12):2640-5, 2011. e-Pub 2011. PMID: 21415239.
102. Choi HH, Gully C, Su CH, Velazquez-Torres G, Chou PC, Tseng C, Zhao R, Phan L, Shaiken T, Chen J, Yeung SC, Lee MH. COP9 signalosome subunit 6 stabilizes COP1, which functions as an E3 ubiquitin ligase for 14-3-3σ. Oncogene 30(48):4791-801, 2011. e-Pub 2011. PMID: 21625211.
103. Liu Z, Feng H, Yeung SC, Zheng Z, Liu W, Ma J, Zhong FT, Luo H, Cheng C. Extended transsternal thymectomy for the treatment of ocular myasthenia gravis. Ann Thorac Surg 92(6):1993-9, 2011. PMID: 22115207.
104. Feng YH, Velazquez-Torres G, Gully C, Chen J, Lee MH, Yeung SC. The impact of type 2 diabetes and antidiabetic drugs on cancer cell growth. J Cell Mol Med 15(4):825-36, 2011. e-Pub 2010. PMID: 20455996.
105. Zhao R, Yeung SC, Chen J, Iwakuma T, Su CH, Chen B, Qu C, Zhang F, Chen YT, Lin YL, Lee DF, Jin F, Zhu R, Shaikenov T, Sarbassov D, Sahin A, Wang H, Wang H, Lai CC, Tsai FJ, Lozano G, Lee MH. Subunit 6 of the COP9 signalosome promotes tumorigenesis in mice through stabilization of MDM2 and is upregulated in human cancers. J Clin Invest 121(3):851-65, 2011. e-Pub 2011. PMID: 21317535.
106. Su CH, Zhao R, Zhang F, Qu C, Chen B, Feng YH, Phan L, Chen J, Wang H, Wang H, Yeung SC, Lee MH. 14-3-3sigma exerts tumor-suppressor activity mediated by regulation of COP1 stability. Cancer Res 71(3):884-94, 2011. e-Pub 2010. PMID: 21135113.
107. Zhao R, Fuentes-Mattei E, Velazquez-Torres G, Su CH, Chen J, Lee MH, Yeung SC. Exenatide improves glucocorticoid-induced glucose intolerance in mice. Diabetes Metab Syndr Obes 4:61-5, 2011. e-Pub 2011. PMID: 21448323.
108. Feng YH, Wang YW, Yeung SCJ. Current concepts of pain management for cancer patients. Oncology Review 2(3):154-63, 2011.
109. Lee MH, Zhao R, Phan L, Yeung SC. Roles of COP9 signalosome in cancer. Cell Cycle 10(18):3057-66, 2011. e-Pub 2011. PMID: 21876386.
110. Cancer Res.. Su CH, Zhao R, Zhang F, Qu C, Chen B, Feng YH, Phan L, Chen J, Wang H, Yeung SC, Lee MH. 14-3-3sigma exerts tumor-suppressor activity mediated by regulation of COP1 stability 71(3):884-94, 2011. e-Pub 2010. PMID: 21135113.
111. Yeung SC, Habra MA, Thosani SN. Lung cancer-induced paraneoplastic syndromes. Curr Opin Lulm Med 17(4):260-8, 2011. e-Pub 2011. PMID: 21577115.
112. Hanzelka KM, Zalpour A, Afshar-Kharghan V, Fitousis K, Anderlini P, Yeung SC. Severe thrombosis and acute thrombocytopenia in a cancer patient. Am J Hematol 85(11):887-90, 2010. PMID: 20721891.
113. Su CH, Zhao R, Velazquez-Torres G, Chen J, Gully C, Yeung SC, Lee MH. Nuclear export regulation of COP1 by 14-3-3s in response to DNA damage. Mol Cancer 9:243, 2010. e-Pub 2010. PMID: 20843328.
114. Chen B, Liu C-G, Jin F, Sun Y-N, Zhao T-T, Zhang L-N, Li S, Yeung SC. The role of fine-wire localization breast biopsy in the management of BI-RADS category 3-5 non-palpable breast lesions in northeastern Chinese women. Health 2(4):291-294, 2010.
115. Gully CP, Zhang F, Chen J, Yeung JA, Velazquez-Torres G, Wang E, Yeung SC, Lee MH. Antineoplastic effects of an Aurora B kinase inhibitor in breast cancer. Mol Cancer 9:42, 2010. e-Pub 2010. PMID: 20175926.
116. Jin Q, Yuan LX, Boulbes D, Baek JM, Wang YN, Gomez-Cabello D, Hawke DH, Yeung SC, Lee MH, Hortobagyi GN, Hung MC, Esteva FJ. Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells. Breast Cancer Res 12(6):R96, 2010. e-Pub 2010. PMID: 21080941.
117. Becker TK, Yeung S-CJ. Drug-induced QT interval prolongation in cancer patients. Oncology Review 4(4):223-32, 2010.
118. Cheng C, Wu G, Yeung SC, Li R, Bella AE, Pang J, Zhong FT, Luo H, Jin Y, Pan J. Serum protein profiles in myasthenia gravis. Ann Thorac Surg 88(4):1118-23, 2009. PMID: 19766792.
119. Li D, Yeung SC, Hassan MM, Konopleva M, Abbruzzese JL. Antidiabetic Therapies Affect Risk of Pancreatic Cancer. Gastroenterology 137(2):482-8, 2009. e-Pub 2009. PMID: 19375425.
120. Chen J, Kobayashi M, Darmanin S, Qiao Y, Gully C, Zhao R, Kondo S, Wang H, Wang H, Yeung SC, Lee MH. Hypoxia-Mediated Up-Regulation of Pim-1 Contributes to Solid Tumor Formation. Am J Pathol 175(1):400-11, 2009. e-Pub 2009. PMID: 19528349.
121. Chen J, Kobayashi M, Darmanin S, Qiao Y, Gully C, Zhao R, Yeung SC, Lee MH. Pim-1 plays a pivotal role in hypoxia-induced chemoresistance. Oncogene 28(28):2581-92, 2009. e-Pub 2009. PMID: 19483729.
122. Pan J, Song E, Cheng C, Lee MH, Yeung SC. Farnesyltransferase inhibitors-induced autophagy: alternative mechanisms?. Autophagy 5(1):129-31. e-Pub 2009. PMID: 19066466.
123. Gullly C, Chen J, Zhang FM, Yeung J, Yeung SCJ, Lee MH. Antineoplastoc effects of an Aurora-B kinase inhibitor in breast cancer. Cancer Research 69, 2009. PMID: WOS: 000209702802191.
124. Lee MH, Yeung SC. Intercepting Akt with DNAzyme: A nasopharyngeal carcinoma story. Cancer Biol Ther 8(4):372-4, 2009. e-Pub 2009. PMID: 19182540.
125. Yeung SJ, Pan J, Lee MH. Roles of p53, MYC and HIF-1 in regulating glycolysis - the seventh hallmark of cancer. Cell Mol Life Sci 65(24):3981-99, 2008. PMID: 18766298.
126. Pan J, Chen B, Su CH, Zhao R, Xu ZX, Sun L, Lee MH, Yeung SC. Autophagy induced by farnesyltransferase inhibitors in cancer cells. Cancer Biol Ther 7(10):1679-84. e-Pub 2008. PMID: 18769123.
127. Cheng C, Yeung SC, Zhong FT, Xiong Y, Luo HH, Ji S, Pan J. Aneurysmal bone cyst in the first rib. Ann Thorac Surg 85(6):2118-20, 2008. PMID: 18498837.
128. Yao JC, Phan A, Hoff PM, Chen HX, Charnsangavej C, Yeung SC, Hess K, Ng C, Abbruzzese JL, Ajani JA. Targeting vascular endothelial growth factor in advanced carcinoid tumor: a random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alpha-2b. J Clin Oncol 26(8):1316-23, 2008. PMID: 18323556.
129. Oncology Reviews. Feng Y-H, Wang Y-W, Yeung S-CJ. Current concepts of pain management for cancer patients 2(3):154, 2008.
130. Yeung SC, Gully C, Lee MH. Aurora-B kinase inhibitors for cancer chemotherapy. Mini Rev Med Chem 8(14):1514-25, 2008. e-Pub 2008. PMID: 19075809.
131. Yeung SC, She M, Yang H, Pan J, Sun L, Chaplin D.. Combination Chemotherapy including Combretastatin A4 Phosphate and Paclitaxel is Effective against Anaplastic Thyroid Cancer in a Nude Mouse Xenograft Model. J Clin Endocrinol Metab 92(92:2902-2909):2902-9, 2007. e-Pub 2007. PMID: 17550961.
132. Yao JC, Zhang JX, Rashid A, Yeung SC, Szklaruk J, Hess K, Xie K, Ellis L, Abbruzzese JL, Ajani JA. Clinical and in vitro studies of imatinib in advanced carcinoid tumors. Clin Cancer Res 13(1):234-40, 2007. PMID: 17200360.
133. Huyghe E, Nohra J, Caron P, Bennet A, Khedis M, Otal P, Soulie M, Yeung SC, Plante P. Lethal posttraumatic rupture of a pheochromocytoma: lesson from a postmortem diagnosis. Urol Int 79(1):83-5, 2007. PMID: 17627175.
134. She M, Yeung SC. Combining a matrix metalloproteinase inhibitor, a farnesyltransferase inhibitor, and a taxane improves survival in an anaplastic thyroid cancer model. Cancer Lett 238(2):197-201, 2006. e-Pub 2005. PMID: 16154259.
135. She M, Yang H, Sun L, Yeung SC. Redox control of manumycin A-induced apoptosis in anaplastic thyroid cancer cells: involvement of the xenobiotic apoptotic pathway. Cancer Biol Ther 5(3):275-80, 2006. e-Pub 2006. PMID: 16410725.
136. Mambo E, Chatterjee A, Xing M, Tallini G, Haugen BR, Yeung SC, Sukumar S, Sidransky D. Tumor-specific changes in mtDNA content in human cancer. Int J Cancer 116(6):920-4, 2005. PMID: 15856456.
137. Escalante CP, Weiser MA, Lam T, Ho V, Yeung SC. Hypertension in cancer patients seeking acute care: an opportunity to intervene. Am J Med Sci 330(3):120-7, 2005. PMID: 16174995.
138. Pan J, Huang H, Sun L, Fang B, Yeung SC. Bcl-2-associated X protein is the main mediator of manumycin a-induced apoptosis in anaplastic thyroid cancer cells. J Clin Endocrinol Metab 90(6):3583-91, 2005. e-Pub 2005. PMID: 15769983.
139. Pan J, She M, Xu ZX, Sun L, Yeung SC. Farnesyltransferase inhibitors induce DNA damage via reactive oxygen species in human cancer cells. Cancer Res 65(9):3671-81, 2005. PMID: 15867362.
140. She M, Pan I, Sun L, Yeung SC. Enhancement of manumycin A-induced apoptosis by methoxyamine in myeloid leukemia cells. Leukemia 19(4):595-602, 2005. PMID: 15744347.
141. Dackiw A, Pan J, Xu G, Yeung SC. Modulation of parathyroid hormone-related protein levels (PTHrP) in anaplastic thyroid cancer. Surgery 138(3):456-463, 2005. PMID: 16213899.
142. Pan J, Yeung SC. Recent adevances in understanding the antineoplastic mechanisms of farnesyltransferase inhibitors. Cancer Res 65(20):9109-12, 2005. e-Pub 2005. PMID: 16230362.
143. Pan JX, Huang HZ, Sun LL, Fang BL, Yeung SCJ. Bcl-2-associated X protein is the main mediator of manumycin A-induced apoptosis in anaplastic thyroid cancer cells. Journal of Clinical Endocrinology & Metabolism 90(6):3583-91, 2005. PMID: WOS:000229351000064.
144. Schiff BA, McMurphy AB, Jasser SA, Younes MN, Doan D, Yigitbasi OG, Kim S, Zhou G, Mandal M, Bekele BN, Holsinger FC, Sherman SI, Yeung SC, El-Naggar AK, Myers JN. Epidermal growth factor receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer. Clin Cancer Res 10(24):8594-602, 2004. PMID: 15623643.
145. Hu W, Wu W, Verschraegen CF, Chen L, Mao L, Yeung SC, Kudelka AP, Freedman RS, Kavanagh JJ. Proteomic identification of heat shock protein 70 as a candidate target for enhancing apoptosis induced by farnesyl transferase inhibitor. Proteomics 3(10):1904-11, 2003. PMID: 14625852.
146. Yang HL, Pan JX, Sun L, Yeung SC. p21 Waf-1 (Cip-1) enhances apoptosis induced by manumycin and paclitaxel in anaplastic thyroid cancer cells. J Clin Endocrinol Metab 88(2):763-72, 2003. PMID: 12574211.
147. Ghori FY, Gutterman-Litofsky DR, Jamal A, Yeung SC, Arem R, Sherman SI. Socioeconomic factors and the presentation, management, and outcome of patients with differentiated thyroid carcinoma. Thyroid 12(11):1009-16, 2002. PMID: 12490079.
148. Hu W, Wu W, Yeung SC, Freedman RS, Kavanagh JJ, Verschraegen CF. Increased expression of heat shock protein 70 in adherent ovarian cancer and mesothelioma following treatment with manumycin, a farnesyl transferase inhibitor. Anticancer Res 22(2A):665-72, 2002. PMID: 12014635.
149. Gonzales, J, Yeung, SJ, Smith, JA. A high performance liquid chromatography assay validation of manumycin A in mouse plasma. J Chromatography B 776:177-182, 2002.
150. Pan J, Xu G, Yeung SC. Cytochrome c release is upstream to activation of caspase-9, caspase-8, and caspase-3 in the enhanced apoptosis of anaplastic thyroid cancer cells induced by manumycin and paclitaxel. J Clin Endocrinol Metab 86(10):4731-40, 2001. PMID: 11600533.
151. Xu, GP, Pan, J, Martin, C, Yeung, SC. The role of angiogenesis inhibition in the in vivo antineoplastic effect of manumycin and paclitaxel against anaplastic thyroid carcinoma. J. Clin. Endocrinol. Metab 86:1769-1777, 2001. PMID: 11297616.
152. Yeung SC, Xu G, Pan J, Christgen M, Bamiagis A. Manumycin enhances the cytotoxic effect of paclitaxel on anaplastic thyroid carcinoma cells. Cancer Res 60(3):650-6, 2000. PMID: 10676649.
153. Yeung SJ, McCutcheon IE, Schultz P, Gagel RF. Use of long-term intravenous phosphate infusion in the palliative treatment of tumor-induced osteomalacia. J Clin Endocrinol Metab 85(2):549-55, 2000. PMID: 10690854.
154. Liao W, Yeung SC, Chan L. Proteasome-mediated degradation of apolipoprotein B targets both nascent peptides cotranslationally before translocation and full-length apolipoprotein B after translocation into the endoplasmic reticulum. J Biol Chem 273(42):27225-30, 1998. PMID: 9765244.
155. Yeung SC, Eton O, Burton DW, Deftos LJ, Vassilopoulou-Sellin R, Gagel RF. Hypercalcemia due to parathyroid hormone-related protein secretion by melanoma. Horm Res 49(6):288-91, 1998. PMID: 9623520.
156. Yeung SC, Chiu AC, Vassiliopoulou-Sellin R, Gagel RF. The endocrine effects of nonhormonal antineoplastic therapy. Endocr Rev 19(2):144-72, 1998. e-Pub 1997. PMID: 9570035.
157. Yeung SCJ, Chan L. Hepatic apoliprotein B biogenesis: An update. Trends in Cardiovascular Medicine 8(1):8-14, 1998. PMID: WOS:000072165200003.
158. Yeung SC, Anderson J, Kobayashi K, Oka K, Chan L. Production of rabbit polyclonal antibody against apobec-1 by genetic immunization. J Lipid Res 38(12):2627-32, 1997. PMID: 9458285.
159. Yeung SJ, Chen SH, Chan L. Ubiquitin-proteasome pathway mediated intracellular degradation of apolipoprotein B. Biochemistry 35(43):13843-8, 1996. PMID: 8901527.
160. Yeung, SJ, Go, R, Balasubramanyam, A. Rectal administration of iodide and propylthiouracil in the treatment of thyroid storm. Thyroid 5(5):403-5, 1995. PMID: 8563481.
161. Raju, U, Nunez-Regueiro, M, Cook, R, Kaetzel, MA, Yeung, SJ, Eskin, A. Identification of an annexin-like protein and its possible role in the Aplysia eye circadian system. J Neurochem 61(4):1236-45, 1993. PMID: 8376982.
162. Bem WT, Yeung SJ, Belcheva M, Barg J, Coscia CJ. Age-dependent changes in the subcellular distribution of rat brain mu-opioid receptors and GTP binding regulatory proteins. J Neurochem 57(5):1470-7, 1991. PMID: 1655974.
163. Raju U, Yeung SJ, Eskin A. Involvement of proteins in light resetting ocular circadian oscillators of Aplysia. Am J Physiol 258(1 Pt 2):R256-62, 1990. PMID: 2154135.
164. Szucs M, Bem WT, Yeung S-CJ, Coscia CJ. Characterization of Intracellular Opioid Binding-Sites and G-Regulatory Proteins in Neonatal and Adult-Rat Brain,. European Journal of Pharmacology 186(6):2311, 1990. e-Pub 1993. PMID: WOS:A1990DU77300287.
165. Yeung SJ, Eskin A. Responses of the circadian system in the Aplysia eye to inhibitors of protein synthesis. J. Biol. Rhythms 3:225-36, 1988.
166. Yeung SJ, Eskin A. Involvement of a specific protein in the regulation of a circadian rhythm in Aplysia eye. Proc Natl Acad Sci U S A 84(1):279-83, 1987. PMID: 3025861.
167. Eskin A, Yeung SJ, Klass MR. Requirement for protein synthesis in the regulation of a circadian rhythm by serotonin. Proc Natl Acad Sci U S A 81(23):7637-41, 1984. PMID: 6095312.
168. Bonnie E. Gould Rothberg, MD, PhD, MPH 1; Tammie E. Quest, MD2; Sai-Ching J. Yeung, MD, PhD3; Lorraine C. Pelosof, MD, PhD4; David E. Gerber, MD5; Justin A. Seltzer, MD6; Jason J. Bischof, MD7; Charles R. Thomas, Jr, MD8; Nausheen Akhter, MD9; Mira Mamtani, MD, MSEd10; Robin E. Stutman, MD11; Christopher W. Baugh, MD, MBA12; Venkataraman Anantharaman, MBBS, FRCP Edin.13; Nicholas R. Pettit, DO, PhD14; Adam D. Klotz, MD11; Michael A. Gibbs, MD15; Demetrios N. Kyriacou, MD, PhD16,1. Oncologic emergencies and urgencies: A comprehensive review.
169. Jason J. Bischof a,*, Mohamed I. Elsaid b, John F.P. Bridges b, Ashley E. Rosko c, Carolyn J. Presley d, Beau Abar e, David Adler e, Aveh Bastani f, Christopher W. Baugh g, Steven L. Bernstein h, Christopher J. Coyne i, Danielle D. Durham j, Corita R. Grudzen k, Daniel J. Henning l, Matthew F. Hudson m, Adam Klotz n, Gary H. Lyman o, Troy E. Madsen p, Cielito C. Reyes-Gibby q, Juan Felipe Rico r, Richard J. Ryan s, Nathan I. Shapiro t, Robert Swor u, Charles R. Thomas v, Arvind Venkat w, Jason Wilson x, Sai-Ching Jim Yeung q, Sule Yilmaz y, Jeffrey M. Caterino. Characterization of older adults with cancer seeking acute emergency department care: A prospective observational study. Journal of Geriatric Oncology.
170. Qdaisat A, Bedrose S, Ezzeldin O, Moawad A, Yeung S, Elsayes K, Habra M. The prevalence and spectrum of reported incidental adrenal abnormalities in abdominal computed tomography of cancer patients: The experience of a comprehensive cancer center. Frontiers in Endocrinology, section Adrenal Endocrinology.
171. Krishnamani P, Qdaisat A, Wattana M, Lipe D, Sandoval M, Elsayem A, Cruz-Carreras M, Yeung S, Chaftari P. Characteristics and Outcomes of Patients with Cancer Pain Placed in an Emergency Department Observation Unit. cancers.

Invited Articles

1. Yeung SCJ, Habra M. PTHLH (Parathyroid hormone-like hormone). Atlas Genet Cytogenet Oncol Haematol(17):94(1), 2013.
2. Yeung SCJ, Habra M. Thyroid: Anaplastic (undifferentiated) carcinoma. Atlas Genet Cytogenet Oncol Haematol(16):935(9), 2013. e-Pub 2013.
3. Lee MH, Zhao R, Phan L, Yeung SC. Roles of COP9 signalosome in cancer. Cell Cycle 10(18):3057-66, 2011. e-Pub 2011. PMID: 21876386.
4. Yeung SC, Habra MA, Thosani SN. Lung cancer-induced paraneoplastic syndromes. Curr Opin Pulm Med 17(4):260-8, 2011. PMID: 21577115.
5. Lee MH, Yeung SC. Intercepting Akt with DNAzyme: A nasopharyngeal carcinoma story. Cancer Biol Ther 8(4):372-4. e-Pub 2009. PMID: 19182540.
6. Yeung SCJ, Habra MA. PTHLH (parathyroid hormone-like hormone). Atlas Genet Cytogenet Oncol Haematol(12):234(9), 2008. e-Pub 2007.
7. Yeung SCJ. Thyroid: Anaplastic (undifferentiated) carcinoma. Atlas Genet Cytogenet Oncol Haematol 12(6):477(80), 2008.
8. Pan J, Yeung SC. Recent advances in understanding the antineoplastic mechanisms of farnesyltransferase inhibitors. Cancer Res 65(20):9109-12, 2005. PMID: 16230362.
9. Chui AC, Yeung SC. Diagnostic Challenge: An endocrinologic enigma. Cortlandt Forum 13(3):55-57, 2000.
10. Chui AC, Yeung SJ. Clinical Update: Hypothyroidism. Cortlandt Forum 13(12):111-17, 2000.
11. Yeung, SJ, Chui, AC and Balasubramanyam, A. Diagnostic Challenge: A young woman with no thirst for life. Cortlandt Forum 13(4):42-43, 2000.
12. Yeung SC, Chui AC. Difficult Diagnosis: A tale of two lesions – Cushing’s syndrome in a woman with lung and adrenal masses. Primary Care & Cancer 20:23-27, 2000.
13. Yeung SC, Amato R, Gagel RF. Difficult Diagnosis: What is causing this patient's muscle weakness?. Primary Care & Cancer 19:5-9, 1999.
14. Yeung SC, Chan L. Hepatic apolipoprotein B biogenesis: an update. Trends Cardiovasc Med 8(1):8-14, 1998. PMID: 21235906.

Manuals, Teaching Aids, Other Teaching Publications

1. Busaidy NL, Busaidy KF, Yeung SC. A 45-year-old man with a maxillary mass and hypercalcemia, 2005.
2. Jimenez C, Yeung SC. What is causing this patient bone pain and muscular weakness? A case report of Fanconi syndrome complicated with osteomalacia due to a lymphoma, 2003.

Other Articles

1. Yeung SC, Habra MA, Thosani SN Lung cancer-induced paraneoplastic syndromes. Curr Opin Pulm Med 17(4):260-8, 2011. PMID: 21577115.
2. Yeung SC, Gully C, Lee MH Aurora-B kinase inhibitors for cancer chemotherapy. Mini Rev Med Chem 8(14):1514-25, 2008. PMID: 19075809.
3. Feng YH, Wang YW, Yeung SC Current concepts of pain management for cancer patients. Oncol Rev 2(3):204-213, 2008.
4. Yeung SC, Chiu AC, Vassilopoulou-Sellin R, Gagel RF The endocrine effects of nonhormonal antineoplastic therapy. Endocr Rev 19(2):144-72, 1998. PMID: 9570035.

Abstracts

1. Chaftari P, Chaftari A, Hachem R, Yeung S, Dagher H, Jiang Y, Malek A, Mulanovich V, Raad, I.. The Role of Procalcitonin (PCT) and Lactic Acid in Febrile Neutropenic Cancer Patients in an Oncological Emergency Center, 2020.
2. Qdaisat A, Wu C, Alsoud S, Yeung SJ. Performance of clinical decision rules in detective venous thromboembolism in cancer patients presented to the emergency department. Oncologic Emergency Medicine Conference, UT MD Anderson Cancer Center, 2018.
3. Qdaisat A, AlSoud R, Wu C, Abdel-Razeq H, Yeung SJ. Diagnostic accuracy of D-dimer in cancer-associated venous thromboembolism. Oncologic Emergency Medicine Conference, UT MD Anderson Cancer Center, 2018.
4. Qdaisat A, Wu C, Yeung SJ. Clinical prediction rule for cancer-associated venous thromboembolism in patients presenting to the emergency department. National Comprehensive Cancer Network 23rd Annual Conference, 2018.
5. Yang R, Shi W, Yeung S. Improved prognosis of lung cancer patients in Xuanwei-Fuyuan counties, a high-incidence region of Yunnan Province in China, compared with the rest of Yunnan Province. National Comprehensive Cancer Network 23rd Annual Conference, 2018.
6. Banala SR, Yeung SC, Rice TW, Reyes-Gibby CC, Wu CC, Todd KH, Peacock WF, Alagappan K. Discharge or admit? Emergency Department management of incidental pulmonary embolism in patients with cancer. Division of Internal Medicine 2017 Research Retreat, The University of Texas MD Anderson Cancer Center, Houston TX, 2017.
7. Banala SR, Todd KH, Cruz Carreras MT, Yeung SC, Sandoval M, Reyes-Gibby CC. Hypertension is a predictor of Emergency Department visits among patients with head and neck cancer. Division of Internal Medicine 2017 Research Retreat, The University of Texas MD Anderson Cancer Center, Houston TX, 2017.
8. Elsayem AF, Bruera E, Valentine AD, Warneke CL, Wood GL, Yeung SC, Page VD, Silvestre J, Brock PA, Todd KH. Outcomes among patients with advanced cancer and delirium presenting to the Emergency Department. Division of Internal Medicine 2017 Research Retreat, The University of Texas MD Anderson Cancer Center, Houston TX, 2017.
9. Reyes-Gibby CC, Melkonian SC, Wang J, Yu RK, Shelburne SA, Lu C, Gunn GB, Chambers MS, Hanna EY, Yeung SC, Shete S. Identifying novel genes and biological processes relevant to the development of cancer therapy-induced mucositis: an informative gene network analysis. Division of Internal Medicine 2017 Research Retreat, The University of Texas MD Anderson Cancer Center, Houston TX, 2017.
10. Wechsler AH, Qdaisat A, Yeung SC. Incidence and mortality of spontaneous intracranial hemorrhage in oncologic patients presenting to the Emergency Department of a comprehensive cancer center. Division of Internal Medicine 2017 Research Retreat, The University of Texas MD Anderson Cancer Center, Houston TX, 2017.
11. Yang Z, Yang R, Kwak MJ, Qdaisat A, Lin J, Begley CE, Reyes-Gibby CC, Yeung SC. Oncologic emergencies in a cancer center Emergency Department and in general Emergency Departments countywide and nationwide. Division of Internal Medicine 2017 Research Retreat, The University of Texas MD Anderson Cancer Center, Houston TX, 2017.
12. Bulbul A, Araujo-Mino EP, Huber M, Bautista A, Thein KZ, Husain H, Awasthi S, Yeung S-CJ, Khorsand M. Serious Cardiovascular Events and Clinical Outcomes in Secondary Polycythemia: Efficacy of Conventional Phlebotomy and Proposed Hematocrit Target. American Society of Hematology, 2017.
13. Bulbul A, Thein KZ, Araujo-Mino EP, Yeung S-CJ, Tsao-Wei D, Huber M, Chouial S,Awasthi S, Khorsand M. Prevalence and Prognostic Significance of CD5 Immunohistochemistry in De-Novo DLBCL in a Western Population Cohort. American Society of Hematology, 2017.
14. Win MA, Thein KZ, Qdaisat A, Han MM, Yeung SJ. Side efects of immune checkpoint therapy in cancer patients visiting the Emergency Department of a comprehensive cancer center. National Comphrehensive Cancer Network 22nd Annual Conference, 2017.
15. Lee MH, Fang L, Chen B, Choi HH, Shin JH, Phan L, Yeung S-C. COP9 signalosome in regulating EGFR oncogenic signals. Biomedical Research and Therapy 4(S)::S5-S, 2017.
16. Liu W, Qdaisat A, Yeung J, Lopez G, Weinberg JS, Choen L, Bruerar E, Yeung S-CJ. Association between clinical and biochemical indices and survival in glioblastoma patients. American Society of Clinical Oncology, 2017.
17. Thein K, Yeung SC, Oo TH. A Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCT) in Ambulatory Thromboprophylaxis (ATP) in Patients with Lung Cancer Receiving Chemotherapy. The 58th Annual Meeting and Exposition of American Society of Hematology, 2016.
18. Thein KZ, Win MA, Yeung SC, Oo TH. Risk of Bleeding from Primary Thromboprophylaxis (PTP) in Patients with Solid Cancer Receiving Chemotherapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCT). The 58th Annual Meeting and Exposition of American Society of Hematology, 2016.
19. Elsayem AF, Valentine AD, Warneke CL, Page VD, Bruera E, Yeung SC, Brock PA, Silvestre J, Holmes HM, Todd KH. Delirium Assessment in Advanced Cancer Patients Presenting to the Emergency Department of a Comprehensive Cancer Center. Palliative Care in Oncology Symposium, 2015.
20. Habra M, Yeung SC, Lee MH. Hepatocyte Growth Factor/cMET Pathway Activation Enhances Cancer Hallmarks in Adrenocortical Carcinoma: A Potential Therapeutic Target. ENDO, 2015.
21. Tu SM, Bilen MA, Tu ZH, General R, Ward JF, Pisters LL, General R, Chen AH, Nieto Y, Pagliaro LC, Yeung SJ, Logothetis C, Lin SH, Gorlov I. Nonseminomatous germ cell tumor of the testis: Prognostic factors for a lethal phenotype. 2014 Genitourinary Cancers Symposium, 2014. e-Pub 2014.
22. Elsayem A, Merriman K, Gonzalez C, Yeung SC, Chaftari P, Henderson J, Todd KH. Intensive Care Unit Admissions and Mortality in Patients admitted through the Emergency Department of a Comprehensive Cancer Center. Proceedings of ASCO 2014, 2014. e-Pub 2014.
23. Fuentes-Mattei E, Phan L, Velazquez-Torres G, Zhang F, Chou PC, Shin JH, Choi HH, Chen JS, Gully C, Carlock C, Zhao R, Qi Y, Zhang Y, Wu Y, Esteva FJ, McKeehan WL, Ensor J, Hortobagyi GN, Pusztai L, Symmans WF, Lee MH, Yeung SC. Obesity Induces Functional Transcriptomic Changes in Estrogen Receptor-Positive Breast Cancer. DoIM Research Retreat, 2013.
24. Chou PC, Zhao R, Fuentes-Mattei E, Velazquez-Torre G, Zhang F, Qu C, Phan L, Lee J, Elliott A, Bankson JA, Wu Y, Wang H, Esteva FJ, Ensor J, Hortobagyi GN, Lee MH, Yeung SC. Anti-insulin resistance treatments suppress breast cancer growth and alter metabolic status. DoIM Research Retreat, 2013.
25. Shin J, Yang TY, Chou PC, Phan L, Chen J, Vázquez Vélez GE, Yeung SC, Lee MH. COP1 ubiquitin ligase Regulates FBW7 stability in a AKT dependent manner. DoIM Research Retreat, 2013.
26. Fuentes-Mattei E, Zhang F, Velazquez-Torres G, Chou PC, Phan L, Shin JH, Choi HH, Chen JS, Gully C, Colin C, Zhao R, Wu Y, Esteva FJ, McKeehan WL, Ensor J, Hortobagyi GN, Pusztai L, Symmans WF, Lee MH, Yeung SC. Obesity Accelerates Oncogene-Driven Estrogen Receptor-Positive Breast Carcinogenesis, Coincident with Changes in Tumor Metabolism and Enhanced Epithelial-Mesenchymal Transition Gene Expression. Keystone Symposia X4 Tumor Metabolism Keystone, Colorado, 2013.
27. Fuentes-Mattei E, Phan L, Velazquez-Torres G, Zhang F, Chou PC, Phan L, Shin JH, Choi HH, Chen JS, Gully C, Colin C, Zhao R, Wu Y, Esteva FJ, Lou Y, McKeehan WL, Ensor J, Hortobagyi GN, Pusztai L, Symmans WF, Lee MH, Yeung SC. Obesity Induces Functional Transcriptomic Changes Enhancing the Cancer Hallmarks of ER-Positive Breast Cancer. Division of Internal Medicine Research Retreat, The University of Texas MD Anderson Cancer Center, 2013.
28. Fuentes-Mattei E, Phan L, Velazquez-Torres G, Zhang F, Chou PC, Phan L, Shin JH, Choi HH, Chen JS, Gully C, Colin C, Zhao R, Wu Y, Esteva FJ, Lou Y, McKeehan WL, Ensor J, Hortobagyi GN, Pusztai L, Symmans WF, Lee MH, Yeung SC. Obesity Induces Functional Transcriptomic Changes Enhancing the Cancer Hallmarks of ER-Positive Breast Cancer. 2013 Gordon Research Seminar (GRS)/ Gordon Research Conference (GRC) Cellular & Molecular Mechanism of Toxicology, 2013.
29. Fuentes-Mattei E, Phan L, Velazquez-Torres G, Zhang F, Chou PC, Phan L, Shin JH, Choi HH, Chen JS, Gully C, Colin C, Zhao R, Wu Y, Esteva FJ, Lou Y, McKeehan WL, Ensor J, Hortobagyi GN, Pusztai L, Symmans WF, Lee MH, Yeung SC. Obesity Induces Functional Transcriptomic Changes Enhancing the Cancer Hallmarks of ER-Positive Breast Cancer. 2013 San Antonio Breast Cancer Symposium, 2013.
30. Phan L, Chou PC, Velazquez-Torres G, Samudio I, Parreno K, Huang Y, Tseng C, Vu T, Gully C, Su CH, Wang E, Chen J, Choi HH, Fuentes-Mattei E, Shin JH, Shiang C, Grabiner B, Blonska M, Skerl S, Shao Y, Cody D, Delacerda J, Kingsley C, Webb D, Carlock C, Zhou Z, Hsieh YW, Lee J, Elliott A, Ramirez M, Bankson J, Hazle J, Wang Y, Li L, Weng S, Lin X, Wang HA, Wang H, Zhang A, Xia X, Wu Y, Yang W, Pusztai L, Yeung SC, Lee MH. 14-3-3sigma regulates cancer metabolic reprogramming by targeting c-Myc. Proceedings of Cell Symposium Hallmarks of Cancer, 2012.
31. Elsayem AF, Gonzalez CE, Yeung SC, Merriman K, Todd KH. In-hospital mortality of patients admitted through the emergency department of a comprehensive cancer center. ASCO Annual Meeting, Chicago, IL, 2012.
32. Fuentes-Mattei E, Gully C, Velazquez-Torres G, Shin JH, Chen JS, Choi HH, Chou PC, Adams HP, Phan L, Yang TY, Yeung SC, Lee MH. Aurora B binds p53 during both interphase and mitosis, phosphorylates it and promotes its degradation. Division of Internal Medicine Retreat, MD Anderson Cancer Center, 2012.
33. Fuentes-Mattei E, Gully C, Velazquez-Torres G, Shin JH, Chen JS, Choi HH, Chou PC, Adams HP, Phan L, Yang TY, Yeung SC, Lee MH. Aurora B binds p53 during both interphase and mitosis, phosphorylates it and promotes its degradation. Late-Breaking Research: Molecular and Cellular Biology 4, AACR Annual Meeting, Chicago, IL, 2012.
34. Phan L, Chou PC, Samudio I, Velazquez-Torres G, Parreno K, Huang Y, Tseng C, Vu T, Gully C, Su CH, Wang E, Chen J, Choi HH, Fuentes-Mattei E, Shin JH, Shiang C, Grabiner B, Blonska M, Shao Y, Cody D, Delacerda J, Kingsley C, Webb D, Carlock C, Zhou Z, Hsieh YC, Lee J, Elliott A, Ramirez M, Bankson J, Hazle J, Wang Y, Li L, Weng X, Lin X, Wang H, Wang H, Zhang A, Xia X, Wu Y, Yang W, Pusztai L, Yeung SC, Lee MH. The tumor suppressor 14-3-3sigma is a new regulator of cancer metabolism. Award Finalist - Basic Science Research, MD Anderson Cancer Center Trainee Research Day, 2012.
35. Fuentes-Mattei E, Zhang F, Velazquez-Torres G, Chou PC, Phan L, Shin JH, Choi HH, Chen JS, Gully C, Carlock C, Zhao R, Wu Y, Esteva FJ, McKeehan WL, Ensor J, Hortobagyi GN, Pusztai L, Symmans WF, Lee MH, Yeung SC. Obesity accelerates oncogene-driven estrogen receptor-positive breast carcinogenesis and cancer progression with enhanced glycolysis and epithelial–mesenchymal transition. Jackson Lab's 21th Annual Short Course on Experimental Model of Human Cancer, 2012.
36. Luo Y, Yang C, Lee MH, Yeung SC, McKeehan WL. Deficiency of Metabolic Regulator FGFR4 Elevates Endocrine FGF19 and FGF21 and Suppresses TGFa-driven Breast Cancer Progression. 3rd International Conference on Fibroblast Growth Factors. Wenzhou, China, 2012.
37. Yeung SC, Zhao R, Chou B, Velazquez-Torres G, Fuentes-Mattei E, Lee MH. Diabetes mellitus accelerates ErbB2-induced breast carcinogenesis and shortens the survival of a mouse model of breast cancer and diabetes. Era of Hope Conference, Orlando, Florida, 2011.
38. Phan L, Samudio I, Chou PC, Parreno K, Velazquez-Torres G, Gully C, Huang Y, Tseng C, Vu T, Shao Y, Cody D, Delacerda J, Kingsley C, Zhang A, Xia X, Su CH, Choi HH, Wang E, Chen J, Carlock C, Zhou Z, Fuentes-Mattei E, Shin JH, Hsieh YC, Yeung SC, Lee MH. The tumor suppressor 14-3-3 sigma regulates glycolysis by targeting c-MYC. Era of Hope Conference, Orlando, Florida, 2011.
39. Fuentes-Mattei E, Velázquez-Torres G, Zhao R, Zhang F, Chou B, Gully C, Carlock C, Phan L, Wang H, Lee MH, Yeung SC. MMTV-TGFα: Ay/a obese mouse model to study the effect of obesity and anti-insulin resistance treatments on ER-positive breast cancer. AMGEN Award Finalist - Basic Science Research, MD Anderson Cancer Center Trainee Research Day, 2011.
40. Fuentes-Mattei E, Velázquez-Torres G, Zhao R, Zhang F, Chou B, Gully C, Carlock C, Phan L, Wang H, Lee MH, Yeung SC. The effect of obesity on ER-positive breast cancer. Division of Internal Medicine Retreat, MD Anderson Cancer Center, Houston, TX, 2011.
41. Fuentes-Mattei E, Velázquez-Torres G, Zhao R, Zhang F, Chou B, Gully C, Carlock C, Phan L, Wang H, Lee MH, Yeung SC. Development of MMTV-TGFα: Ay/a obese mouse model to study the effect of obesity on ER-positive breast cancer. Genes and Development Graduate Program Retreat, MD Anderson Cancer Center, Houston, Texas, 2011.
42. Phan L, Velazquez‐Torres G, Samudio I, Gully C, Su CH, Wen Y, Yeung SC, Lee MH. 14-3-3 sigma suppresses cancer glycolysis. Scientific Session of 7th Vietnam Education Foundation and Rensselaer Polytechnic Institute Annual Conference, 2010.
43. Gully C, Wang E, Velazquez-Torres G, Chen J, Carlock C, Yu W, Phan L, Zhang F, Yeung SC, Lee MH. Aurora B kinase has multi-layered control of tumor suppressor p53. MD Anderson Cancer Center Trainee Research Day, 2010.

Book Chapters

1. Rajha E, Yeung S. Adverse effects of antineoplastic agents approved in the last decade. In: Oncologic Emergency Medicine: Principles and Practice. 2nd Edition. Springer International Publishing, 2021.
2. Yeung S, Chaftari P, Manzullo E. The MD Anderson Manual of Medical Oncology. In: Oncologic Emergencies. 4th, 2021.
3. Bast RC Jr, Croce CM, Hait WN, Hong WK, Kufe DW, Piccart-Gebhart M, Pollack RE, Weichselbaum RR, Yang H and Holland, JF (Editors). Oncologic Emergencies. In: Holland-Frei Cancer Medicine. 9th Edition. Wiley-Blackwell: Hoboken, New Jersey, 2017.
4. Bast RC Jr, Croce CM, Hait WN, Hong WK, Kufe DW, Piccart-Gebhart M, Pollack RE, Weichselbaum RR, Yang H and Holland, JF (Editors). Endocrine Complications and Paraneoplastic Syndromes. In: Holland-Frei Cancer Medicine. 9th Edition. Wiley-Blackwell: Hoboken, New Jersey, 2017.
5. Liu W, Yeung SC. Metabolic and Endocrine Oncologic Emergencies. In: Oncologic Emergencies. 1st Edition. Springer-Verlag New York, 2016.
6. Todd KH, Thomas CR (Editors). Diarrhea in Cancer Patients. In: Oncologic Emergency Medicine: Principles and Practice. Springer International Publishing, 2016.
7. Todd KH, Thomas CR (Editors). Endocrine and Metabolic Emergencies. In: Oncologic Emergency Medicine: Principles and Practice. Springer International Publishing, 2016.
8. Manzullo E, Yeung SJ, Gonzalez C, Escalante C (Editors). Metabolic and Endocrine Oncologic Emergencies. In: Oncologic Emergencies (M.D. Anderson Cancer Care Series). MD Anderson Cancer Center Press, 2016.
9. Kantarjian H and Wolff R (Editors). Oncologic Emergencies. In: The MD Anderson Manual of Medical Oncology. 3rd Edition. McGraw Hill Medical: New York, NY, 2016.
10. Yeung SJ, Escalante C. Cardiac emergencies in the cancer patient. In: Cancer and the Heart. 2nd Edition. PMPH-USA, 2012.
11. Yeung SJ, Gagel RF. Endocrine complications and paraneoplastic syndromes. In: Cancer Medicine. 8th Edition. BC Decker Inc: Hamilton, Ontario, Canada, 2010.
12. Yeung SJ, Escalante C. Oncologic Emergencies. In: Cancer Medicine. 8th Edition. BC Decker Inc: Hamilton, Ontario, Canada, 2010.
13. Pan J, Yeung SC. Farnesyltransferase inhibitors of microbial origins in cancer therapy. In: Emerging cancer therapy: microbial approaches and biotechnological tools. John Wiley & Sons Inc: Hoboken, NJ, 2010.
14. Lee MH, Yang H, Zhao R, Yeung SJ. Roles of negative and positive growth regulators in nasopharyngeal carcinoma. In: Apoptosis in Carcinogenesis and Chemotherapy. Springer Science + Business Media BV: Dordrecht, The Netherlands, 273-294, 2009.
15. Lee MH, Yeung SJ, Yang HY. 14-3-3 family proteins and checkpoint response. In: Cancer Drug Discovery and Development: Checkpoint response in cancer therapy. Humana Press: Totowa, NJ, 2009.
16. Hu MI, Yeung SJ, Gagel RF. Endocrine paraneoplastic syndromes. In: Medical Care of Cancer Patients. BC Decker Inc: Hamilton, Ontario, Canada, 2009.
17. Yeung SJ, Gagel RF. Endocrine neoplastic syndromes. In: Medical Care of Cancer Patients. BC Decker Inc: Hamilton, Ontario, Canada, 2009.
18. Yeung SJ, Gagel RF. Pituitary and adrenal complications in cancer patients. In: Medical Care of Cancer Patients. BC Decker Inc: Hamilton, Ontario, Canada, 2009.
19. Yeung SJ. Cancer screening in cancer survivors. In: Medical Care of Cancer Patients. BC Decker Inc: Hamilton, Ontario, Canada, 2009.
20. Row M, Yeung SJ. Emergency care: special considerations in cancer patients. In: Medical Care of Cancer Patients. BC Decker Inc: Hamilton, Ontario, Canada, 2009.
21. Yeung SJ, Escalante C, Gagel RF. Survivorship - a reversal of fortune. In: Medical Care of Cancer Patients. BC Decker Inc: Hamilton, Ontario, Canada, 2009.
22. Habra MA, Busaidy NL, Yeung SJ, Vassilopoulou-Sellin R. Endocrine manifestations of non-endocrine tumors. In: The MD Anderson Manual of Medical Oncology. McGraw-Hill Professional: New York, NY, 2006.
23. Yeung SJ, Escalante C. Cardiac emergencies in the cancer patient. In: Cancer and the Heart. PMPH-USA, 2006.
24. Yeung SJ. Preclinical Studies of Chemotherapy for Undifferentiated Thyroid Carcinoma, Chapter 7. In: Advances in Molecular and Cellular Endocrinology. Elsevier Science: Amsterdam, Holland, 117-144, 2005.
25. Yeung SJ, Escalante C. Oncologic Emergencies. In: Cancer Medicine. 7th Edition. BC Decker Inc: Hamilton, Ontario, Canada, 2005.
26. Yeung SJ, Gagel RF. Endocrine complications and paraneoplastic syndromes. In: Cancer Medicine. 7th Edition. BC Decker Inc: Hamilton, Ontario, Canada, 2005.
27. Yeung SJ, Escalante C. Oncologic Emergencies. In: Cancer Medicine. 6th Edition. BC Decker Inc: Hamilton, Ontario, Canada, 2003.
28. Yeung SJ, Gagel RF. Endocrine complications and paraneoplastic syndromes. In: Cancer Medicine. 6th Edition. BC Decker Inc: Hamilton, Ontario, Canada, 2003.
29. Levett M, Row M, Yeung SJ. Miscellaneous Oncologic Emergencies. In: Oncologic Emergency. BC Decker Inc: Hamilton, Ontario, Canada, 2002.
30. Yeung SJ, Lazo G, Gagel RF. Endocrine and Metabolic Emergencies. In: Oncologic Emergency. BC Decker Inc: Hamilton, Ontario, Canada, 2002.
31. Yeung SJ. Orthopedic Oncologic Emergencies. In: Oncologic Emergency. BC Decker Inc: Hamilton, Ontario, Canada, 2002.
32. Yeung SJ, Gagel RF. Endocrine complications. In: Cancer Medicine. 5th Edition. BC Decker Inc: Hamilton, Ontario, Canada, 2389-2398, 2000.
33. Yeung SJ, Hubbard JR. Endocrine and metabolic diseases. In: Primary Medicine for Psychiatrists: Practitioner’s Guide. Plenum Publishing Corp: New York, NY, 1-27, 1997.

Books (edited and written)

1. Manzullo E, Yeung SC, Gonzalez CE, Escalante C. Oncologic Emergency. In: MD Anderson Cancer Care Series. Ed(s) Manzullo E, Yeung SC, Gonzalez CE, Escalante C. MD Anderson Cancer Center Press, 2016.
2. Todd KH, Thomas CR (Editors). Oncologic Emergency Medicine: Principles and Practice. Ed(s) Yeung SJ (Section Editor). Springer International Publishing, 2016.
3. Yeung SJ, Escalante C, Gagel RF (Editors). Medicine Care of Cancer Patients. B. C. Decker Inc: Ontario, Canada, 2009.
4. Yeung SJ, Escalante C. Oncologic Emergency. B. C. Decker Inc: Canada, Ontario, 2002.